vinpocetine has been researched along with Cerebrovascular Disorders in 51 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (31.37) | 18.7374 |
| 1990's | 12 (23.53) | 18.2507 |
| 2000's | 16 (31.37) | 29.6817 |
| 2010's | 6 (11.76) | 24.3611 |
| 2020's | 1 (1.96) | 2.80 |
| Authors | Studies |
|---|---|
| Butakova, JS; Parshin, MS; Samartsev, IN; Zhivolupov, SA | 1 |
| Al-Gareeb, AI; Albuhadilly, AK; Alkuraishy, HM | 1 |
| Lagoda, OV; Lokshina, AB; Stakhovskaia, LV; Timerbaeva, SL; Zakharov, VV | 1 |
| Filimonov, VA; Kliueva, VN; Kondrasheva, IN | 1 |
| Feher, G; Horvath, B; Kesmarky, G; Koltai, K; Komoly, S; Szapary, L; Toth, K | 1 |
| Konchugova, TV; Orekhova, EM; Prikazchikova, OA; Raĭgorodskiĭ, IuM; Svistunov, AA | 1 |
| Chukanova, EI | 2 |
| Chukanova, EI; Levin, IaI; Nikonov, AA; Petrova, EA; Peverennova, IE; Skoromets, AA; Spirin, NN; Tanashian, MM | 1 |
| Lobzin, VIu; Odinak, MM | 1 |
| Chugunov, AV; Kamchatnov, PR; Zaĭtsev, KA | 1 |
| Kasatkin, DS | 1 |
| Medhi, B; Modi, M; Patyar, S; Prakash, A | 1 |
| Balogh, A; Fehér, G; Késmárky, G; Misnyovszky, M; Nagy, K; Németh, G; Németh, GY; Szapáry, L; Tóth, K; Tóth, T | 1 |
| Bönöczk, P; Csiba, L; Gulyás, B; Kárpáti, E; Kiss, B; Nagy, Z; Pánczél, G; Szabó, Z; Vas, A | 1 |
| Bíró, K; Kárpáti, E; Kukorelli, T | 1 |
| Studenikin, VM | 1 |
| Alexy, T; Czopf, I; Horvath, B; Kesmarky, G; Marton, Z; Nagy, F; Sapary, L; Toth, K; Zsots, M | 1 |
| Dzizinskiĭ, AA; Filatova, LN; Kuklin, SG; Protasov, KV; Shprakh, VV; Sinkevich, DA | 1 |
| Nikitina, VV; Pravdina, AN; Zapatrina, OV | 1 |
| Bagoly, E; Fehér, G; Szapáry, L | 1 |
| Murashko, NK | 1 |
| Lil'in, ET; Mar'in, MI; Trubnikov, VI; Vavilova, TA | 1 |
| Eremeeva, SV; Shtok, VN | 1 |
| Polgár, M; Vereczkey, L | 1 |
| Miyazaki, M | 1 |
| Opekunova, GT; Podvigin, AV; Shapovalov, VM; Storokha, AA | 1 |
| Chukhrova, VA; Lebedeva, NV; Nepesov, RR; Solov'ev, OU | 1 |
| Balkay, L; Bereczki, D; Boros, I; Csiba, L; Emri, M; Fekete, I; Galuska, L; Gulyás, B; Kerényi, L; Lehel, S; Márián, T; Molnár, T; Szakáll, S; Trón, L; Varga, J | 1 |
| Bereczki, D; Fekete, I | 1 |
| Bönöczk, P; Chou, YH; Farde, L; Gulyás, B; Halldin, C; Karlsson, P; Swahn, CG | 1 |
| Adam-Vizi, V; Bönöczk, P; Gulyás, B; Kapás, M; Kárpáti, E; Kiss, B; Koncz, I; Nemes, A; Szántay, C; Vas, A; Zelles, T | 1 |
| Klein, M; Szobor, A | 1 |
| Hayakawa, M | 1 |
| Burtsev, EM; Savkov, VS; Shprakh, VV | 2 |
| Dorogiĭ, AN; Ishchenko, MM; Nechaĭ, EE; Shkrobot, SI | 1 |
| Buslo, EA; Galusha, AI; Shevchenko, VA; Zozulia, AA; Zozulia, IS | 1 |
| Khrapova, EV; Lebedeva, NV | 1 |
| Karaban', IN; Man'kovskiĭ, NB; Mints, AIa | 1 |
| Matsumoto, S; Tamaki, N | 1 |
| Man'kovsky, NB; Minz, AY | 1 |
| Bánki, MC; Farsang, C; Juvancz, P; Kertész, G | 1 |
| Astengo, F; Balestreri, R; Fontana, L | 1 |
| Borak, VT; Ishchenko, MM; Shkrobot, SI | 1 |
| Berdichevskiĭ, MIa; Dronnikova, IS; Onopchenko, NV | 1 |
| Kusunoki, T; Matsumoto, S; Tamaki, N | 1 |
| Hanasaki, N; Marimoto, Y | 1 |
| Kovács, L | 1 |
| Ebi, O | 1 |
| Ishchenko, MM; Shkrobot, SI | 1 |
7 review(s) available for vinpocetine and Cerebrovascular Disorders
| Article | Year |
|---|---|
Role of vinpocetine in cerebrovascular diseases.
Topics: Animals; Brain Ischemia; Cerebrovascular Disorders; Humans; Memory; Neuroprotective Agents; Nootropic Agents; Stroke; Vinca Alkaloids | 2011 |
[Vinpocetin in neurological diseases].
Topics: Animals; Anticonvulsants; Cerebrovascular Circulation; Cerebrovascular Disorders; Clinical Trials as Topic; Cognition; Cognition Disorders; Dementia, Vascular; Hemorheology; Humans; Microcirculation; Nervous System Diseases; Neuroprotective Agents; Stroke; Treatment Outcome; Vasodilator Agents; Vinca Alkaloids | 2012 |
Clinical and non-clinical investigations using positron emission tomography, near infrared spectroscopy and transcranial Doppler methods on the neuroprotective drug vinpocetine: a summary of evidences.
Topics: Aged; Animals; Cerebrovascular Disorders; Clinical Trials as Topic; Humans; Macaca fascicularis; Neuroprotective Agents; Spectroscopy, Near-Infrared; Tomography, Emission-Computed; Ultrasonography, Doppler, Transcranial; Vinca Alkaloids | 2002 |
[The role of vinpocetine in the treatment of cerebrovascular diseases based in human studies].
Topics: Acute Disease; Brain Ischemia; Cerebrovascular Circulation; Cerebrovascular Disorders; Chronic Disease; Glucose; Hemorheology; Humans; Neuroprotective Agents; Nootropic Agents; Quality of Life; Stroke; Treatment Outcome; Vasodilator Agents; Vinca Alkaloids | 2007 |
A systematic review of vinpocetine therapy in acute ischaemic stroke.
Topics: Cerebrovascular Disorders; Humans; Ischemia; Randomized Controlled Trials as Topic; Substance-Related Disorders; Time Factors; Vasodilator Agents; Vinca Alkaloids | 1999 |
Role of sodium channel inhibition in neuroprotection: effect of vinpocetine.
Topics: Animals; Calcium; Calcium Channel Blockers; Cerebrovascular Disorders; Humans; Neuroprotective Agents; Vinca Alkaloids | 2000 |
[Agents to improve cerebrovascular circulation and cerebral metabolism--vinpocetine].
Topics: Animals; Brain; Cerebrovascular Circulation; Cerebrovascular Disorders; Cyclic GMP; Dogs; Glucose; Humans; Mice; Oxygen Consumption; Rats; Vasodilator Agents; Vinca Alkaloids | 1985 |
12 trial(s) available for vinpocetine and Cerebrovascular Disorders
| Article | Year |
|---|---|
Vinpocetine and pyritinol: a new model for blood rheological modulation in cerebrovascular disorders—a randomized controlled clinical study.
Topics: Aged; Blood Proteins; Blood Viscosity; Cerebrovascular Disorders; Drug Synergism; Erythrocytes; Female; Humans; Male; Middle Aged; Pyrithioxin; Randomized Controlled Trials as Topic; Rheology; Vinca Alkaloids | 2014 |
[The use of the combined drug vinpotropil at early stages of cerebrovascular insufficiency].
Topics: Aged; Aged, 80 and over; Calcium Channel Blockers; Cerebrovascular Disorders; Cognition; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Male; Middle Aged; Nootropic Agents; Piracetam; Psychometrics; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome; Vasodilator Agents; Vinca Alkaloids | 2007 |
Effect of parenteral or oral vinpocetine on the hemorheological parameters of patients with chronic cerebrovascular diseases.
Topics: Administration, Oral; Adult; Aged; Blood Viscosity; Cerebrovascular Circulation; Cerebrovascular Disorders; Erythrocyte Aggregation; Erythrocyte Deformability; Female; Fibrinogen; Hematocrit; Hemorheology; Humans; Injections, Intravenous; Male; Middle Aged; Neuroprotective Agents; Phytotherapy; Pilot Projects; Platelet Aggregation; Single-Blind Method; Vinca; Vinca Alkaloids | 2009 |
[Efficacy of dynamic magnetic therapy in the complex treatment of cognitive disturbances in patients with chronic cerebrovascular insufficiency].
Topics: Aged; Antihypertensive Agents; Brain; Cerebrovascular Disorders; Cognition Disorders; Female; Humans; Magnetic Field Therapy; Male; Middle Aged; Treatment Outcome; Vinca Alkaloids | 2009 |
[Cavinton in the complex treatment of patients with chronic cerebrovascular insufficiency].
Topics: Aged; Aged, 80 and over; Blood Pressure; Calcium Channel Blockers; Cerebrovascular Disorders; Cognition; Disease Progression; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Male; Middle Aged; Motor Activity; Treatment Outcome; Vinca Alkaloids | 2009 |
[A multicenter program on assessment of efficacy and safety of a new therapeutic scheme for patients with chronic cerebrovascular insufficiency].
Topics: Adult; Aged; Calcium Channel Blockers; Cerebrovascular Disorders; Chronic Disease; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Middle Aged; Neuroprotective Agents; Prospective Studies; Psychometrics; Quality of Life; Surveys and Questionnaires; Treatment Outcome; Vinca Alkaloids | 2009 |
[Trial of using Cavinton in cerebrovascular disorders].
Topics: Adult; Aged; Cerebrovascular Circulation; Cerebrovascular Disorders; Clinical Trials as Topic; Humans; Injections, Intravenous; Middle Aged; Pulse; Tablets; Time Factors; Vasodilator Agents; Vinca Alkaloids | 1982 |
The effect of a cerebral vasodilator, vinpocetine, on cerebral vascular resistance evaluated by the Doppler ultrasonic technique in patients with cerebrovascular diseases.
Topics: Aged; Carotid Artery, Internal; Cerebrovascular Disorders; Humans; Laser-Doppler Flowmetry; Middle Aged; Pulsatile Flow; Regional Blood Flow; Ultrasonography, Doppler; Vascular Resistance; Vasodilator Agents; Vinca Alkaloids | 1995 |
Examinations of the relative fluidity in cerebrovascular disease patients.
Topics: Adult; Blood Viscosity; Cerebrovascular Disorders; Ergot Alkaloids; Erythrocyte Indices; Female; Hematocrit; Humans; Male; Middle Aged; Pentoxifylline; Vasodilator Agents; Vinca Alkaloids | 1992 |
[Use of sermion, Cavinton and trental in patients with cerebrovascular disorders].
Topics: Administration, Oral; Adult; Aged; Cerebrovascular Circulation; Cerebrovascular Disorders; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Ergolines; Humans; Infusions, Intravenous; Middle Aged; Nicergoline; Pentoxifylline; Theobromine; Vinca Alkaloids | 1990 |
A double-blind placebo controlled evaluation of the safety and efficacy of vinpocetine in the treatment of patients with chronic vascular senile cerebral dysfunction.
Topics: Aged; Aged, 80 and over; Cerebrovascular Disorders; Clinical Trials as Topic; Cognition Disorders; Double-Blind Method; Female; Humans; Male; Mental Status Schedule; Middle Aged; Neurologic Examination; Placebos; Time Factors; Vasodilator Agents; Vinca Alkaloids | 1987 |
Open-labeled phase III clinical trials with vinpocetine in Japan.
Topics: Activities of Daily Living; Adult; Aged; Aged, 80 and over; Cerebrovascular Disorders; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Vasodilator Agents; Vinca Alkaloids | 1985 |
32 other study(ies) available for vinpocetine and Cerebrovascular Disorders
| Article | Year |
|---|---|
[The open observational study of aceclofenac and vinpocetine effectiveness and tolerability in treatment of patients with chronic cerebrovascular disease after COVID-19 (AQUA study)].
Topics: Aged; Cerebrovascular Disorders; COVID-19; COVID-19 Drug Treatment; Diclofenac; Female; Humans; Male; Middle Aged; Post-Acute COVID-19 Syndrome; Vinca Alkaloids | 2021 |
[Vinpotropile in the treatment of cerebral vascular diseases].
Topics: Administration, Oral; Adult; Blood Flow Velocity; Calcium Channel Blockers; Cerebrovascular Circulation; Cerebrovascular Disorders; Dose-Response Relationship, Drug; Drug Combinations; Female; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nootropic Agents; Piracetam; Plethysmography, Impedance; Treatment Outcome; Ultrasonography, Doppler, Transcranial; Vasodilator Agents; Vinca Alkaloids | 2007 |
[The use of cavinton in the therapy of cognitive disorders in patients with discirculatory encephalopathy].
Topics: Adult; Aged; Aged, 80 and over; Cerebrovascular Disorders; Cognition; Cognition Disorders; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Middle Aged; Nootropic Agents; Treatment Outcome; Ultrasonography, Doppler, Transcranial; Vinca Alkaloids | 2009 |
[Chronic disorders of cerebral blood circulation: possibilities of the use of cavinton].
Topics: Antihypertensive Agents; Cerebrovascular Circulation; Cerebrovascular Disorders; Humans; Vinca Alkaloids | 2010 |
[Efficacy of cavinton in the treatment of patients with chronic blood flow insufficiency. Russian multicenter clinical-epidemiological program "CALIPSO"].
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Cerebrovascular Disorders; Female; Humans; Hypertension; Male; Middle Aged; Russia; Treatment Outcome; Vinca Alkaloids | 2010 |
[Polymorphic effects of cavinton: experimental and clinical evidence].
Topics: Calcium Channel Blockers; Cerebrovascular Disorders; Clinical Trials as Topic; Humans; Vinca Alkaloids | 2010 |
[Investigation of vasoactive agents with indole skeletons at Richter Ltd].
Topics: Animals; Cerebrovascular Disorders; Clinical Trials as Topic; Drug Industry; Humans; Hungary; Indoles; Neuroprotective Agents; Vasoconstrictor Agents; Vinca Alkaloids | 2002 |
[Use of cavinton in neuropaediatrics].
Topics: Adolescent; Age Factors; Aged; Cerebral Palsy; Cerebrovascular Disorders; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Male; Nervous System Diseases; Neuroprotective Agents; Sex Factors; Vasodilator Agents; Vinca Alkaloids | 2004 |
[Effect of cavinton on the hemorheological parameters of chronic cerebrovascular patients].
Topics: Blood Viscosity; Cerebrovascular Circulation; Cerebrovascular Disorders; Chronic Disease; Erythrocyte Aggregation; Female; Fibrinogen; Follow-Up Studies; Humans; Injections, Intravenous; Male; Middle Aged; Neuroprotective Agents; Treatment Outcome; Vinca Alkaloids | 2006 |
[Cavinton forte treatment of cerebral vascular insufficiency in patients with coronary heart disease and arterial hypertension].
Topics: Aged; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cerebrovascular Disorders; Coronary Disease; Electrocardiography, Ambulatory; Female; Follow-Up Studies; Humans; Hypertension; Male; Middle Aged; Neuroprotective Agents; Treatment Outcome; Vinca Alkaloids | 2006 |
[About cavinton therapy of the patients with brain vascular diseases].
Topics: Cerebrovascular Circulation; Cerebrovascular Disorders; Female; Humans; Infusions, Intravenous; Middle Aged; Neuroprotective Agents; Treatment Outcome; Vinca Alkaloids | 2007 |
[Diagnostics and treatment tactics for chronic cerebrovascular disorders with the use of single photon emission computed tomography].
Topics: Brain; Calcium Channel Blockers; Cerebrovascular Circulation; Cerebrovascular Disorders; Chronic Disease; Female; Humans; Male; Middle Aged; Tomography, Emission-Computed, Single-Photon; Vinca Alkaloids | 2008 |
[Role of psychophysiologic characteristics of patients in the efficacy of treatment with cavinton].
Topics: Adult; Aged; Central Nervous System; Cerebrovascular Disorders; Female; Humans; Male; Middle Aged; Vinca Alkaloids | 1983 |
Determination of apovincaminic acid in human plasma by gas-liquid chromatography.
Topics: Cerebrovascular Disorders; Chromatography, Gas; Humans; Time Factors; Vasodilator Agents; Vinca Alkaloids | 1982 |
[The intravenous laser therapy of circulatory encephalopathy].
Topics: Aged; Brain; Cerebrovascular Disorders; Cinnarizine; Electroencephalography; Humans; Laser Therapy; Methods; Middle Aged; Plethysmography, Impedance; Vasodilator Agents; Vinca Alkaloids | 1996 |
[Treatment of circulatory encephalopathy with Cavinton].
Topics: Cerebrovascular Circulation; Cerebrovascular Disorders; Drug Administration Routes; Electroencephalography; Female; Humans; Male; Middle Aged; Treatment Outcome; Vasodilator Agents; Vinca Alkaloids | 1997 |
Cerebral effects of a single dose of intravenous vinpocetine in chronic stroke patients: a PET study.
Topics: Aged; Blood Flow Velocity; Blood-Brain Barrier; Brain; Cerebrovascular Circulation; Cerebrovascular Disorders; Female; Glucose; Humans; Infusions, Intravenous; Male; Middle Aged; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Ultrasonography, Doppler, Transcranial; Vinca Alkaloids | 1998 |
[Cerebral uptake and metabolism of (11C) Vinpocetine in monkeys: PET studies].
Topics: Animals; Brain; Cerebrovascular Disorders; Disease Models, Animal; Humans; Injections, Intravenous; Macaca fascicularis; Platelet Aggregation Inhibitors; Radioligand Assay; Tomography, Emission-Computed; Vinca Alkaloids | 1999 |
Effect of vinpocetine on red blood cell deformability in stroke patients.
Topics: Aged; Centrifugation; Cerebrovascular Disorders; Erythrocyte Deformability; Female; Humans; Male; Middle Aged; Vasodilator Agents; Vinca Alkaloids | 1992 |
[A differential approach to cavinton and finoptin treatment of patients with circulatory encephalopathies].
Topics: Aged; Cerebrovascular Circulation; Cerebrovascular Disorders; Humans; Middle Aged; Phosphodiesterase Inhibitors; Vasodilator Agents; Verapamil; Vinca Alkaloids | 1992 |
[Vasoactive and cardiotonic drugs in the treatment of initial manifestations of cerebrovascular insufficiency in occlusive diseases of major blood vessels of the head].
Topics: Adult; Aged; Aminophylline; Arterial Occlusive Diseases; Carotid Artery Diseases; Cerebrovascular Disorders; Drug Therapy, Combination; Humans; Middle Aged; Vasodilator Agents; Verapamil; Vertebral Artery; Vinca Alkaloids | 1991 |
[The treatment of hypertension patients with neurological disorders].
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Benzothiadiazines; Cerebrovascular Disorders; Diuretics; Drug Evaluation; Drug Therapy, Combination; Humans; Hypertension; Nervous System Diseases; Piracetam; Sodium Chloride Symporter Inhibitors; Vinca Alkaloids | 1990 |
[Initial dyscirculatory encephalopathy in middle-aged and elderly patients (problems of early diagnosis and therapy)].
Topics: Aged; Cerebrovascular Circulation; Cerebrovascular Disorders; Ergolines; Humans; Middle Aged; Nicergoline; Time Factors; Vasodilator Agents; Vinca Alkaloids | 1989 |
[Effectiveness of using cavinton in patients of different ages with chronic forms of cerebrovascular diseases (clinico-rheographic research)].
Topics: Aged; Aging; Cerebrovascular Circulation; Cerebrovascular Disorders; Chronic Disease; Drug Evaluation; Female; Humans; Hypertension; Intracranial Arteriosclerosis; Male; Middle Aged; Plethysmography, Impedance; Vasodilator Agents; Vinca Alkaloids | 1988 |
Principles of pharmacologic correction of neurologic disorders in initial atherosclerotic encephalopathy.
Topics: Aged; Aging; Arteriosclerosis; Brain; Cerebrovascular Circulation; Cerebrovascular Disorders; Electroencephalography; Evoked Potentials, Visual; Humans; Mental Processes; Middle Aged; Vasodilator Agents; Vinca Alkaloids | 1988 |
Effect of two years' Cavinton treatment on the ECG.
Topics: Aged; Aged, 80 and over; Cerebrovascular Disorders; Double-Blind Method; Electrocardiography; Humans; Middle Aged; Random Allocation; Vasodilator Agents; Vinca Alkaloids | 1987 |
[Effect of cavinton and sulfocamphocain on systemic and cerebral hemodynamics in patients with early forms of cerebrovascular diseases].
Topics: Camphor; Cerebrovascular Circulation; Cerebrovascular Disorders; Drug Combinations; Drug Therapy, Combination; Female; Hemodynamics; Humans; Injections, Intravenous; Male; Middle Aged; Procaine; Time Factors; Vasodilator Agents; Vinca Alkaloids | 1987 |
[Effect of a series of vasoactive drugs on the compensatory adaptive processes of the brain during acute experimental cerebral venous stasis].
Topics: Adaptation, Physiological; Aminophylline; Animals; Brain; Cerebrovascular Disorders; Hydroxyethylrutoside; Pentoxifylline; Rats; Vasodilator Agents; Vinca Alkaloids; Xanthinol Niacinate | 1987 |
The effect of vinpocetine on cerebral blood flow in patients with cerebrovascular disorders.
Topics: Aged; Cerebrovascular Circulation; Cerebrovascular Disorders; Female; Humans; Male; Middle Aged; Time Factors; Vasodilator Agents; Vinca Alkaloids | 1985 |
Effect of TCV-3B tablets on the thyroid function in patients with cerebrovascular disorders.
Topics: Aged; Cerebrovascular Disorders; Female; Humans; Male; Middle Aged; Thyroid Gland; Thyroid Hormones; Vasodilator Agents; Vinca Alkaloids | 1985 |
Cavinton in the treatment of acute stroke.
Topics: Acute Disease; Adult; Aged; Cerebrovascular Disorders; Female; Humans; Male; Middle Aged; Vasodilator Agents; Vinca Alkaloids | 1985 |
[Effect of cavinton on systemic and cerebral hemodynamics of patients with chronic cerebral circulatory insufficiency].
Topics: Adult; Aged; Cerebrovascular Circulation; Cerebrovascular Disorders; Female; Hemodynamics; Humans; Hypertension; Intracranial Arteriosclerosis; Male; Middle Aged; Plethysmography, Impedance; Rheology; Vinca Alkaloids | 1985 |